Photo: Alexey Druzhini/Sputnik/AFP via Getty Images

Russian President Vladimir Putin announced Tuesday that his country has registered a coronavirus vaccine and said that one of his daughters has already been inoculated, AP reports.

Why it matters: Scientists around the world are skeptical about Russia's claims. There is no published scientific data to back up Putin's claims that Russia has a viable vaccine — or that it produces any sort of immunity without significant side effects.

  • A Russian vaccine has not gone through any phase three trials, which are lengthy and involve thousands of participants for testing.
  • Experts caution that introducing a vaccine to the population without widespread testing could have serious negative consequences, including unexpected side effects or simply undermining public trust in their efficacy.

What he said: "I know it has proven efficient and forms a stable immunity, and I would like to repeat that it has passed all the necessary tests," Putin told a news conference.

  • He claimed his daughter is "feeling well and has high number of antibodies."

The state of play: The vaccine race has become a competition between rival global powers. Getting the first viable coronavirus vaccine would be a boon for Russia's international prestige, which Putin is desperate to bolster.

  • According to the U.S, U.K. and Canada, hackers linked to Russian military intelligence have attempted to steal vaccine research in order to aid their own efforts.
  • Former FDA Commissioner Scott Gottlieb tweeted that the announcement "may be another effort to stoke doubts or goad [the U.S.] into forcing early action on our vaccines." He also told CNBC that he "wouldn't take it."

The big picture: There are three vaccines worldwide — one each from the U.S., U.K. and China — that have entered or are headed toward phase three trials.

  • There are at least 16 other vaccines currently in clinical trials in Australia, France, Germany, India, Russia, South Korea, the U.K., the U.S. and China.
  • Experts are increasingly confident that it's no longer a question of if but when vaccines will eventually be available.
  • But they caution that we won't know how effective they are in protecting against COVID-19 — and for how long — until after phase three trials are completed.

Go deeper

Updated 35 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 10 a.m. ET: 32,881,747 — Total deaths: 994,821 — Total recoveries: 22,758,171Map.
  2. U.S.: Total confirmed cases as of 10 a.m. ET: 7,079,909 — Total deaths: 204,503 — Total recoveries: 2,750,459 — Total tests: 100,492,536Map.
  3. States: New York daily cases top 1,000 for first time since June — U.S. reports over 55,000 new coronavirus cases.
  4. Health: The long-term pain of the mental health pandemicFewer than 10% of Americans have coronavirus antibodies.
  5. Business: Millions start new businesses in time of coronavirus.
  6. Education: Summer college enrollment offers a glimpse of COVID-19's effect.

New York daily coronavirus cases top 1,000 for first time since June

Photo: Chip Somodevilla/Getty Images

New York on Friday reported more than 1,000 new coronavirus cases for the first since June.

Why it matters: The New York City metropolitan area was seen as the epicenter of the COVID-19 pandemic throughout the spring. But strict social distancing and mask mandates helped quell the virus' spread, allowing the state to gradually reopen.

22 hours ago - Health

U.S. reports over 55,000 new coronavirus cases

Flags on the Washington National Mall on Sept. 22, each representing 1,000 people killed from the virus. Photo: Chen Mengtong/China News Service via Getty Images

The United States reported 55,054 new coronavirus cases on Friday, according to Johns Hopkins University data.

Why it matters: It was the highest single-day increase since August 14, when the country reported 64,350 new cases over a 24-hour span, and suggests that the U.S. has yet to contain the spread of the virus.